Novartis Ag (NVS) Inventory Average (2009 - 2020)

Novartis Ag (NVS) posted Inventory Average of $84.0 million for Q4 2020, little changed sequentially from $84.0 million in Q3 2020.

Novartis Ag (NVS) Inventory Average (2009 - 2020) Analysis & Trends

Novartis Ag has reported Inventory Average for 6 years, with the latest figure at $84.0 million in Q4 2020.

Quarterly Inventory Average changed N/A year-over-year to $84.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $84.0 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 billion, up 3.06% from the prior year.
Inventory Average steadied at $84.0 million in Q4 2020 per NVS's latest filing, from $84.0 million in the prior quarter.
Over five years, Inventory Average peaked at $3.6 billion in Q3 2018 and troughed at $6.0 million in Q2 2019.
A 3-year average of $1.4 billion and a median of $111.8 million in 2020 frame the typical range for Inventory Average.
The widest YoY moves for Inventory Average: up 1300.0% in 2020, down 95.99% in 2020.
Over 3 years, Inventory Average stood at $3.6 billion in 2018, then slumped by 99.83% to $6.0 million in 2019, then surged by 1300.0% to $84.0 million in 2020.
According to Business Quant data, Inventory Average over the past three periods registered $84.0 million, $84.0 million, and $84.0 million for Q4 2020, Q3 2020, and Q2 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Johnson & Johnson	645.88 Bn	625.12 Bn	17.26 Bn	14.86 Bn
2	AbbVie	463.46 Bn	456.89 Bn	12.70 Bn	5.09 Bn
3	Merck	367.92 Bn	360.78 Bn	12.21 Bn	6.34 Bn
4	Novartis Ag	297.71 Bn	290.02 Bn	11.24 Bn	-
5	Astrazeneca	255.55 Bn	250.65 Bn	12.86 Bn	6.75 Bn
6	Amgen	234.52 Bn	220.53 Bn	7.24 Bn	6.20 Bn
7	Gilead Sciences	178.22 Bn	175.04 Bn	6.22 Bn	1.93 Bn
8	Pfizer	158.57 Bn	146.88 Bn	10.94 Bn	10.31 Bn
9	Gsk	105.32 Bn	101.15 Bn	8.24 Bn	8.36 Bn
10	Sanofi	54.20 Bn	46.82 Bn	10.79 Bn	-

Download Data